The major symposium on RAS inhibitors & mechanisms of resistance at #AACR26 begins with a great introduction by
@cjder23
. Bewildering number of RAS inhibitors under evaluation, as well as a growing combinations in trials. Key differences between allele specific & agnostic KRASi.